--- title: "Haleon PLC (HLN) Receives a Buy from Deutsche Bank" type: "News" locale: "en" url: "https://longbridge.com/en/news/273381115.md" description: "Deutsche Bank analyst Tom Sykes has reiterated a Buy rating on Haleon PLC (HLN) with a price target of p335.00. Sykes, a 3-star analyst, has an average return of 2.1% and a 50.97% success rate. The overall analyst consensus for Haleon PLC is a Moderate Buy, with an average price target of p415.18." datetime: "2026-01-22T13:27:16.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/273381115.md) - [en](https://longbridge.com/en/news/273381115.md) - [zh-HK](https://longbridge.com/zh-HK/news/273381115.md) --- # Haleon PLC (HLN) Receives a Buy from Deutsche Bank In a report released today, Tom Sykes from Deutsche Bank reiterated a Buy rating on Haleon PLC, with a price target of p335.00. ### Claim 50% Off TipRanks Premium - Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions - Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential According to TipRanks, Sykes is a 3-star analyst with an average return of 2.1% and a 50.97% success rate. Sykes covers the Consumer Defensive sector, focusing on stocks such as L’Oreal, Beiersdorf, and DANONE SA. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Haleon PLC with a p415.18 average price target. ### Related Stocks - [VHT.US](https://longbridge.com/en/quote/VHT.US.md) - [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md) - [HLN.US](https://longbridge.com/en/quote/HLN.US.md) - [HAS.UK](https://longbridge.com/en/quote/HAS.UK.md) - [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md) - [XLV.US](https://longbridge.com/en/quote/XLV.US.md) - [IHE.US](https://longbridge.com/en/quote/IHE.US.md) - [AXN.UK](https://longbridge.com/en/quote/AXN.UK.md) - [IBB.US](https://longbridge.com/en/quote/IBB.US.md) ## Related News & Research - [Haleon discloses dividend-driven share purchase by senior independent director](https://longbridge.com/en/news/286785831.md) - [14:05 ETLupin Receives Tentative Approval from U.S. FDA for Revefenacin Inhalation Solution](https://longbridge.com/en/news/286805922.md) - [Bayer Granted Priority Review For Asundexian In Secondary Stroke Prevention](https://longbridge.com/en/news/286884841.md) - [Hays plc (HAS) Receives a Sell from Jefferies](https://longbridge.com/en/news/287256996.md) - [Roth MKM Sticks to Their Buy Rating for Capricor Therapeutics (CAPR)](https://longbridge.com/en/news/286497683.md)